These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11023533)

  • 1. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging.
    Kelavkar UP; Cohen C; Kamitani H; Eling TE; Badr KF
    Carcinogenesis; 2000 Oct; 21(10):1777-87. PubMed ID: 11023533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis.
    Kelavkar UP; Nixon JB; Cohen C; Dillehay D; Eling TE; Badr KF
    Carcinogenesis; 2001 Nov; 22(11):1765-73. PubMed ID: 11698337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of 12/15-lipoxygenase, an ortholog of human 15-lipoxygenase-1, in the prostate tumors of TRAMP mice.
    Kelavkar UP; Glasgow W; Olson SJ; Foster BA; Shappell SB
    Neoplasia; 2004; 6(6):821-30. PubMed ID: 15720809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct effects of annexin A7 and p53 on arachidonate lipoxygenation in prostate cancer cells involve 5-lipoxygenase transcription.
    Torosyan Y; Dobi A; Naga S; Mezhevaya K; Glasman M; Norris C; Jiang G; Mueller G; Pollard H; Srivastava M
    Cancer Res; 2006 Oct; 66(19):9609-16. PubMed ID: 17018618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-lipoxygenase-1 expression upregulates and activates insulin-like growth factor-1 receptor in prostate cancer cells.
    Kelavkar UP; Cohen C
    Neoplasia; 2004; 6(1):41-52. PubMed ID: 15068670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-lipoxygenase-1 overexpression in prostate adenocarcinoma.
    Kelavkar U; Cohen C; Eling T; Badr K
    Adv Exp Med Biol; 2002; 507():133-45. PubMed ID: 12664577
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoxygenase-5 is overexpressed in prostate adenocarcinoma.
    Gupta S; Srivastava M; Ahmad N; Sakamoto K; Bostwick DG; Mukhtar H
    Cancer; 2001 Feb; 91(4):737-43. PubMed ID: 11241241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
    Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR
    Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.
    Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C
    Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence of surfactant protein A and D expression decrement and their localizations in human prostate adenocarcinomas.
    Kankavi O; Baykara M; Eren Karanis MI; Bassorgun CI; Ergin H; Ciftcioglu MA
    Ren Fail; 2014 Mar; 36(2):258-65. PubMed ID: 24168624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between histological type and immunohistochemical profile of prostate cancer and gleason scale gradation.
    Iemelynova AA; Grygorenko VM; Cheremuha SV; Romanenko AM
    Exp Oncol; 2009 Dec; 31(4):246-9. PubMed ID: 20010526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditional expression of human 15-lipoxygenase-1 in mouse prostate induces prostatic intraepithelial neoplasia: the FLiMP mouse model.
    Kelavkar UP; Parwani AV; Shappell SB; Martin WD
    Neoplasia; 2006 Jun; 8(6):510-22. PubMed ID: 16820097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features.
    Machtens S; Serth J; Bokemeyer C; Bathke W; Minssen A; Kollmannsberger C; Hartmann J; Knüchel R; Kondo M; Jonas U; Kuczyk M
    Int J Cancer; 2001 Sep; 95(5):337-42. PubMed ID: 11494236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of 15-lipoxygenase expression and mucus secretion by IL-4 in human bronchial epithelial cells.
    Jayawickreme SP; Gray T; Nettesheim P; Eling T
    Am J Physiol; 1999 Apr; 276(4):L596-603. PubMed ID: 10198357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
    Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
    Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic characteristics of prostatic adenocarcinomas: a mapping analysis of Korean patients.
    Song SY; Kim SR; Ahn G; Choi HY
    Prostate Cancer Prostatic Dis; 2003; 6(2):143-7. PubMed ID: 12806373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma.
    Kallakury BV; Figge J; Ross JS; Fisher HA; Figge HL; Jennings TA
    Hum Pathol; 1994 Jan; 25(1):92-7. PubMed ID: 7508886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.